Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

The Cannigma

JANUARY 21, 2021

It is often called “the mother of all cannabinoids,” and it holds potential as a treatment for conditions such as diabetes, ALS, and Huntington’s disease, although human studies are seriously lacking. And unlike THC and CBD, there’s practically no scientific information about the safety or dosing of CBG-dominant products.

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

Cannabis Law Report

AUGUST 16, 2021

The Ridgell case is an appeal of the Department of Child Safety’s decision to keep a former employee of the department on the registry. Compared to the risks of the pharmaceuticals prescribed for HG that weren’t working, or the risk of having untreated HG, which is a one in three chance of a miscarriage? 10 donors.

Safety 116

Safety Patients Cannabis Law 116

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The bill would allow qualifying patients to access all the alternative treatment centers instead of having to designate just one. NH resident?

Legislation 237

Legislation Patients Decriminalization Access 237

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

JUNE 1, 2021

Steve Barbera is an accomplished cross-functional leader in the healthcare industry, with over 20 years of experience in the development and implementation of complex market access strategies including health policy, pricing and reimbursement, contracts and coding. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JANUARY 16, 2020

Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this. About Devonian. Devonian Health Group Inc.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

The Blunt Truth

DECEMBER 4, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The dispensing of pharmaceuticals.

Marijuana 65

Marijuana Safety Packaging State Laws 65

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” Mitchell et al., Divito & Robert F. Psychiatry May Never Be the Same , N.Y. TIMES (Nov.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Canna Law Blog

MARCH 21, 2020

The report focuses on safety, human and animal drugs, dietary supplements, human and animal food, cosmetics, products outside the FDA’s jurisdiction, and enforcement. That tension stems from the FDA’s treatment of Hemp CBD up to this point. A clear, risk-based enforcement policy would be a welcome change.

CBD 66

CBD Research and Development Hemp Food 66

Cannabis Law Report

JUNE 14, 2019

Agriculture Commissioner Nikki Fried announced Monday a new Medical Marijuana Advisory Committee, which she says will collaborate with the Florida Department of Agriculture and Consumer Services to help improve the state’s medical marijuana policies. Geller’s work focuses on cannabis policy development at the state and federal levels.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

Cannabis Law Report

SEPTEMBER 25, 2019

Psilocybin therapy has the potential to offer relief for the increasing number of Oregonians struggling with depression, anxiety, and addiction who have found no relief from pharmaceuticals. Highlights of the Oregon Psilocybin Services Act include: Safety, practice, and ethical standards for trained and competent facilitators.

Therapy 40

Therapy Pharmaceutical Research and Development Agriculture 40

Cannabis Law Report

OCTOBER 20, 2019

She has also served as the past chair of ABA National Conference of Specialized Court Judges; the President of the American Judge’s Association and the Colorado Women’s Bar Association Foundation, and, as a National Highway Traffic Safety Administration (NHTSA) Judicial Outreach Liaison. vii] Syndros is marketed by Insys Therapeutics.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. By: Kristin Jordan , Senior Counsel. Criterion 2. Criterion 3.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 13, 2019

After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. We heard throughout our inquiry that some pharmaceutical companies were not willing to provide their product for trial,” the report says.

Research and Development 40

Research and Development Clinical Trials Epilepsy Patients 40

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. By: Kristin Jordan , Senior Counsel. Kristin Jordan. Criterion 2. Criterion 3.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

DECEMBER 6, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The dispensing of pharmaceuticals.

Marijuana 45

Marijuana Safety Packaging Law 45

Cannabis Law Report

JUNE 26, 2019

In May 2019, Florida Commissioner of Agriculture Nikki Fried announced that a newly-created and appointed Medical Marijuana Advisory Committee of 18 doctors, lawyers, patients, industry leaders, and advocates will be implemented in order to “advance and modernize policies” to move Florida into the future of medical marijuana.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. Poor quality of government cannabis could be a factor. It simply is a safer substitute.”.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

JULY 18, 2019

On April 15, 2019, Florida released updated Information on How to Get Medical Marijuana Treatment Center License , or MMTC license, in the state to open a clinic or dispensary. . Know the Current Laws and Regulations in Florida courtesy of the Marijuana Policy Project. Dispensary Permiits: Open a Dispensary in Florida.

Marijuana 40

Marijuana Dispensary Research and Development Patients 40

Cannabis Law Report

MAY 28, 2019

5] The most common treatments for PTSD are cognitive behavioral therapy or selective serotonin uptake inhibitors (SSRIs) including Paxil, Zoloft, and Prozac. [6] VHA treatment may require blood testing and urinalysis which can reveal marijuana use. 18] Lyons is one of two VHA treatment facilities in New Jersey. .

Access 49

Access Marijuana Research and Development Programs 49

CannaMD

MARCH 8, 2021

Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. Revising a provision relating to the potency of tetrahydrocannabinol in edibles dispensed by a medical marijuana treatment center [p.1, 2, line 32]. 2, line 38]. 1, line 12]. 2, line 26]. 2, line 29].

THC 116

THC Research and Development Treatment Patients 116

Veriheal

SEPTEMBER 7, 2022

law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. Those who can afford to sacrifice medical program benefits to consistently access medical cannabis treatment will be fine. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C.

Patients 97

Patients Programs Access Treatment 97

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Br J Oral Maxillofac Surg. 2022 Jun;60(5):e677-e690.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 4, 2021

However, it is still impossible to quantify at this stage due to the uncertainty about new variants which may emerge and public policy responses. Eurofins Viracor launched COVID-19 inSIGHT™ T Cell immunity testing to provide healthcare providers with critical insight to aid treatment decisions.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. So just on safety alone, it’s worth using it. I include pharmaceutical drugs in that category. In general, I think that botanical medicine is safer than pharmaceutical medicine.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. There’s an FDA approved synthetic THC drug that is legal and accessible for the treatment of some types of nausea (Marinol), but it’s not popular, and there are often reports of side effects that are not typically seen with whole plant cannabis. Who discovered THC?

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

MARCH 12, 2021

And so, they’re trying to standardize, trying to make sure that doctors are are generally coming at problems from a similar perspective, and especially they’re coming at treatments from a similar perspective. And in my belief, it should be cannabis, because of the safety profile, number one. That is a medical condition.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. The campaign is designed to remind citizens that while cannabis use is now legal, operating vehicles while under its influence remains against the law and is a public safety issue.

Banking 45

Banking Research and Development Legislation Programs 45

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

The Cannigma

DECEMBER 8, 2021

In our conversation with JM, we discuss their work as Development Director for NORML, how their experiences with cancer led them to NORML, and how NORML supports its affiliate chapters that are doing grassroots work to affect public policy changes both locally and internationally. Codi Peterson: Hello, I’m Dr. Codi Peterson.

Access 81

Access Policy Patients Cannabis 81

Cannabis Law Report

JULY 15, 2022

The schedule eight pharmaceutical medicine has gained federal approval to treat conditions including cancer-related pain, nausea and vomiting, multiple sclerosis and epilepsy, and for use in palliative care. But bottlenecks remain to doctors prescribing the controversial treatment. ABC Rural: Jennifer Nichols ).

Medicine 52

Medicine Patients Media Supply Chain 52